Mdd

Do you know how to use assessment tools to guide treatment decisions for your patients with depression? Listen to learn more.

Unlock remission: Learn to identify residual major depressive disorder (MDD) symptoms and personalize timely augmentation strategies with the latest clinical data. Stay current.

Next steps for major depressive disorder (MDD): master the latest clinical data on augmentation and switching strategies.

In this episode of Better Edge, Brandon Hamm, MD, discusses an evidence-based approach to ketamine therapy, including patient selection, safety protocols and a newly expanded infusion suite. He compares ketamine with TMS and ECT, addresses common misconceptions and highlights training...

Join a discussion with the experts for an enlightening journey into the intricate world of managing patients with bipolar depression.

Discover how ketamine, a well-established anesthetic, is gaining attention for its medical applications in anesthesia, pain management, and the treatment of psychiatric conditions. Learn about its method of action, interactions in pain pathways, and its use in managing treatment-resistant...

Can you differentiate bipolar depression from major depressive disorder (MDD)?

Learn about atypical antipsychotics and the best strategies for using them to augment treatment for major depressive disorder (MDD) with inadequate response to initial therapy. Defining Treatment Response in MDD Response to treatment is categorized to establish a clear framework for...

Dr. Roy Perlis is the director of the Center for Quantitative Health at Massachusetts General Hospital and a professor of psychiatry at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Kim and Others. Esketamine for...

The Psychopharmacology Institute is an online platform offering unbiased, practical psychopharmacology updates for healthcare providers, with content updated monthly. It also presents opportunities to earn CME and SA credits. This video lecture explores the evidence of N-Acetyl-Cysteine (NAC)...

Helen Mayberg at the BrainMind Special Forum in Neuromodulation/BCI/AI, interviewed by BrainMind member Jane Roskams. Helen Mayberg is the Director of the Nash Family Center at Mount Sinai for Advanced Circuit Therapeutic, Professor of Neurology, Psychiatry, Neuroscience and Neurosurgery. The...

https://www.hcplive.com/view/ketamine-for-the-treatment-of-mdd Ryan Oakley, MD, takes a closer look at the recent history of ketamine in depression. He also explores the differences between ketamine and esketamine.

Recorded Grand Rounds from Johns Hopkins Psychiatry and Behavioral Sciences. Sandeep Nayak, M.D. presented on the topic “Psilocybin for substance use disorders: an overview of current research and future directions at Hopkins” (November 20, 2023). Please note that the window for earning CME...